These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15313340)

  • 1. Progress in research into systemic sclerosis.
    Kahaleh B
    Lancet; 2004 Aug 14-20; 364(9434):561-2. PubMed ID: 15313340
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.
    Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O
    Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelium in the pathogenesis of systemic sclerosis: is it primary or secondary?
    Furst DE
    J Mal Vasc; 1999 May; 24(2):95-8. PubMed ID: 10399641
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis.
    Breuckmann F; Stuecker M; Altmeyer P; Kreuter A
    Arch Dermatol Res; 2004 Oct; 296(5):235-9. PubMed ID: 15452726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases.
    Distler JH; Beyer C; Schett G; Lüscher TF; Gay S; Distler O
    Arthritis Rheum; 2009 Nov; 60(11):3168-79. PubMed ID: 19877034
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathophysiology of the fibrosis in scleroderma skin.
    Fleischmajer R; Perlish JS
    Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of vascular endothelium in fibroblast activation and tissue fibrosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteoarthropathy).
    Kahaleh MB
    Clin Exp Rheumatol; 1992; 10 Suppl 7():51-6. PubMed ID: 1623675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic sclerosis: from physiopathology to treatment].
    Mouthon L
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S266-72. PubMed ID: 17950498
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibroblast and endothelial apoptosis in systemic sclerosis.
    Jun JB; Kuechle M; Harlan JM; Elkon KB
    Curr Opin Rheumatol; 2003 Nov; 15(6):756-60. PubMed ID: 14569206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
    Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor necrosis factor alpha in systemic scleroderma].
    Alekperov RT; Timchenko AV; Nasonov EL
    Klin Med (Mosk); 2003; 81(12):4-7. PubMed ID: 14971148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic and blood vessels in scleroderma skin, a morphometric analysis.
    Rossi A; Sozio F; Sestini P; Renzoni EA; Khan K; Denton CP; Abraham DJ; Weber E
    Hum Pathol; 2010 Mar; 41(3):366-74. PubMed ID: 20004944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenesis and its association with inflammation and fibrosis in course of the development of scleroderma systematica].
    Radenska-Lopovok SG; Korzenyova EG; Alekperov RT
    Arkh Patol; 2015; 77(2):56-60. PubMed ID: 26027402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.
    Koch AE; Distler O
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S3. PubMed ID: 17767741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sixth international workshop on scleroderma research, Oxford, UK, 30 July--22 August 2000.
    Wollheim FA; Denton CP; Abraham DJ
    Arthritis Res; 2001; 3(1):34-40. PubMed ID: 11269238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma: pathogenic factors and current management.
    Penny R
    Aust N Z J Med; 1978; 8 Suppl 1():143-8. PubMed ID: 365159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.
    Mulligan-Kehoe MJ; Simons M
    Curr Rheumatol Rep; 2007 May; 9(2):173-9. PubMed ID: 17502049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential benefit of statins for vascular disease in systemic sclerosis.
    Kuwana M
    Curr Opin Rheumatol; 2006 Nov; 18(6):594-600. PubMed ID: 17053504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis (scleroderma). Introduction.
    Black CM
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):837-8. PubMed ID: 1750794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.